These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31108174)

  • 1. Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.
    Eddings CR; Arbez N; Akimov S; Geva M; Hayden MR; Ross CA
    Neurobiol Dis; 2019 Sep; 129():118-129. PubMed ID: 31108174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.
    Ryskamp D; Wu J; Geva M; Kusko R; Grossman I; Hayden M; Bezprozvanny I
    Neurobiol Dis; 2017 Jan; 97(Pt A):46-59. PubMed ID: 27818324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip model.
    Lenoir S; Lahaye RA; Vitet H; Scaramuzzino C; Virlogeux A; Capellano L; Genoux A; Gershoni-Emek N; Geva M; Hayden MR; Saudou F
    Neurobiol Dis; 2022 Oct; 173():105857. PubMed ID: 36075537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse.
    Kusko R; Dreymann J; Ross J; Cha Y; Escalante-Chong R; Garcia-Miralles M; Tan LJ; Burczynski ME; Zeskind B; Laifenfeld D; Pouladi M; Geva M; Grossman I; Hayden MR
    Mol Neurodegener; 2018 May; 13(1):25. PubMed ID: 29783994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pridopidine reduces mutant huntingtin-induced endoplasmic reticulum stress by modulation of the Sigma-1 receptor.
    Shenkman M; Geva M; Gershoni-Emek N; Hayden MR; Lederkremer GZ
    J Neurochem; 2021 Jul; 158(2):467-481. PubMed ID: 33871049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models.
    Naia L; Ly P; Mota SI; Lopes C; Maranga C; Coelho P; Gershoni-Emek N; Ankarcrona M; Geva M; Hayden MR; Rego AC
    Neurotherapeutics; 2021 Apr; 18(2):1017-1038. PubMed ID: 33797036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine Protects Neurons from Mutant Huntingtin Toxicity.
    Arbez N; Roby E; Akimov S; Eddings C; Ren M; Wang X; Ross CA
    J Huntingtons Dis; 2019; 8(2):129-143. PubMed ID: 30856117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date.
    Squitieri F; de Yebenes JG
    Drug Des Devel Ther; 2015; 9():5827-33. PubMed ID: 26604684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective Effects of σ
    Jin J; Arbez N; Sahn JJ; Lu Y; Linkens KT; Hodges TR; Tang A; Wiseman R; Martin SF; Ross CA
    ACS Chem Neurosci; 2022 Oct; 13(19):2852-2862. PubMed ID: 36108101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopaminergic stabilizer, (-)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins.
    Ruiz C; Casarejos MJ; Rubio I; Gines S; Puigdellivol M; Alberch J; Mena MA; de Yebenes JG
    Brain Res; 2012 Jun; 1459():100-12. PubMed ID: 22560595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease.
    Francardo V; Geva M; Bez F; Denis Q; Steiner L; Hayden MR; Cenci MA
    Neurotherapeutics; 2019 Apr; 16(2):465-479. PubMed ID: 30756361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pridopidine in the treatment of Huntington's disease.
    Jabłońska M; Grzelakowska K; Wiśniewski B; Mazur E; Leis K; Gałązka P
    Rev Neurosci; 2020 May; 31(4):441-451. PubMed ID: 32083454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor.
    Ryskamp D; Wu L; Wu J; Kim D; Rammes G; Geva M; Hayden M; Bezprozvanny I
    Neurobiol Dis; 2019 Apr; 124():489-504. PubMed ID: 30594810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model.
    Squitieri F; Di Pardo A; Favellato M; Amico E; Maglione V; Frati L
    J Cell Mol Med; 2015 Nov; 19(11):2540-8. PubMed ID: 26094900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons.
    Ruiz-Calvo A; Bajo-Grañeras R; Maroto IB; Zian D; Grabner GF; García-Taboada E; Resel E; Zechner R; Zimmermann R; Ortega-Gutiérrez S; Galve-Roperh I; Bellocchio L; Guzmán M
    Neuropharmacology; 2019 May; 150():134-144. PubMed ID: 30914306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
    McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
    Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pridopidine activates neuroprotective pathways impaired in Huntington Disease.
    Geva M; Kusko R; Soares H; Fowler KD; Birnberg T; Barash S; -Wagner AM; Fine T; Lysaght A; Weiner B; Cha Y; Kolitz S; Towfic F; Orbach A; Laufer R; Zeskind B; Grossman I; Hayden MR
    Hum Mol Genet; 2016 Sep; 25(18):3975-3987. PubMed ID: 27466197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.